On Friday 21st June, Paul, Danny and Madeline will be joining MMX Retail to walk a marathon route around London in support of The Brain Tumour Charity and specifically their funding towards the PNET5 trial.

MMX Partner David Hobbs' son, Alex, was diagnosed with Medulloblastoma (a type of Brain Tumour) in September 2017 aged 3.5 years.  Medulloblastoma is the most common paediatric brain tumour, but as treatments have to target the whole of the brain and spinal cord, they are aggressive and can leave long-term, life-altering disabilities for children who survive.

Through the care Alex has been receiving at GOSH, UCLH and Watford hospitals, his family made the decision to allow Alex to join a Europe-wide treatment trial called PNET5.  

Alex is the first child in the UK on the PNET5 trial.

Part of PNET5 aims to prove that children can benefit from a different treatment regimen that results in fewer immediate side effects and reduced risk of critical long term disabilities, without any negative impact on length of survival.

Please sponsor us if you can - we hope that the PNET5 trial will advance knowledge of Medulloblastoma Brain Tumours and improve treatment for children now and into the future.